Microbix Biosystems Inc. (TSE:MBX) Director Bo Hollas Sells 150,000 Shares

Microbix Biosystems Inc. (TSE:MBX) Director Bo Hollas sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total value of C$73,500.00.

Microbix Biosystems Stock Performance

Microbix Biosystems stock traded down C$0.02 during mid-day trading on Thursday, reaching C$0.47. The company had a trading volume of 190,859 shares, compared to its average volume of 279,751. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. The company has a 50 day moving average of C$0.39 and a 200-day moving average of C$0.35. Microbix Biosystems Inc. has a 52 week low of C$0.29 and a 52 week high of C$0.52. The firm has a market cap of C$64.25 million, a price-to-earnings ratio of 11.75 and a beta of 0.34.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.